Literature DB >> 8030597

Taurine supplementation at three different dosages and its effect on trauma patients.

J D Paauw1, A T Davis.   

Abstract

We studied the effect of different amounts of intravenous taurine supplementation on restoring serum taurine concentrations in trauma patients. The nature of the hypotaurinemia in trauma patients was also studied by following renal-clearance dynamics. Five trauma patients in each of four groups were randomly assigned to receive, in their parenteral nutrition solutions, one of three dosages of taurine (5, 10.8, or 50 mg/kg ideal body wt as group 1, 2, or 3, respectively) or no taurine. Serum taurine concentrations rose significantly over 7 d, relative to control values, in both groups 2 and 3, but even with the highest dosage (group 3) only recovered about one-half of the deficit to the normal value. Despite low serum taurine concentrations in group 3, in contrast with handling of other amino acids, tubular reabsorption of taurine remained abnormally low after 7 d, resulting in a large taurine excretion. Hypotaurinemia in trauma patients persists longer than other hypoaminoacidemias because of depressed renal tubular reabsorption. Even 7 d of a high-dose taurine supplementation does not fully correct the hypotaurinemia of trauma.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8030597     DOI: 10.1093/ajcn/60.2.203

Source DB:  PubMed          Journal:  Am J Clin Nutr        ISSN: 0002-9165            Impact factor:   7.045


  3 in total

1.  Temporal reproducibility of taurine measurements in frozen serum of healthy postmenopausal women.

Authors:  Oktawia P Wójcik; Karen L Koenig; Anne Zeleniuch-Jacquotte; Max Costa; Yu Chen
Journal:  Br J Nutr       Date:  2010-04-26       Impact factor: 3.718

Review 2.  The potential protective effects of taurine on coronary heart disease.

Authors:  Oktawia P Wójcik; Karen L Koenig; Anne Zeleniuch-Jacquotte; Max Costa; Yu Chen
Journal:  Atherosclerosis       Date:  2009-06-11       Impact factor: 5.162

3.  Taurine protects against PMN dysfunction and death in urine.

Authors:  Claire M Condron; Deirdre M Toomey; Rowan G Casey; Tom Creagh; David J Bouchier-Hayes
Journal:  Urol Res       Date:  2004-05-25
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.